Innovating Ovarian Cancer Diagnostics, with Nicole Sandford, CEO of Aspira Women’s Health

How do you bring women’s health innovation to life when the healthcare system is set up to resist change? In this episode, Nicole Sandford, CEO of Aspira Women’s Health, shares the hurdles her company faces in pushing forward diagnostics for ovarian cancer. As a cancer survivor, she also reflects on how her personal health journey fuels her commitment to advancing care for women. Resources and Links: Learn more about Aspira Women’s Health and their ‘Ovasuite’ blood tests: https://aspirawh.com/ Mentioned in the episode: World Ovarian Cancer Coalition: https://worldovariancancercoalition.org/ Related Episodes: ‘Diagnosis’ from Overlooked Season 1: https://overlookedpod.com/episode/diagnosis SUBSCRIBE to the newsletter to get updates on the podcast: sign up at the banner on the website: www.overlookedpod.com. EMAIL US - get in touch with the show: hello@overlookedpod.com DISCLAIMER What you hear and read on ‘Overlooked’ is for general information purposes only and represents the opinions of the host and guests. The content on the podcast and website should not be taken as medical advice. Every person’s body is unique, so please consult your healthcare professional for any medical questions that may arise.

Om Podcasten

Immersive personal stories and conversations about women's health. Overlooked is an award-winning women’s health podcast, hosted by journalist Golda Arthur. In this podcast, we ask, what has been most overlooked, and where is the inequality felt more deeply? The mission of Overlooked is to empower women by helping them advocate better for themselves, and we do this by featuring immersive personal storytelling, and in-depth conversations about women’s health. Overlooked began as a series about ovarian cancer, told through the story of Golda's mother, Teresa. After that first season, the show broadened its focus to look at other topics and stories about women's health, including menopause, endometriosis, motherhood, and survivorship.